ARTICLE | Clinical News
EntreMed preclinical data
April 25, 2005 7:00 AM UTC
In a mouse model of renal carcinoma tumor, proteinase activated receptor (PAR) 2 inhibited tumor growth by 70%. Data were presented at the American Association of Cancer Research meeting in Anaheim. ...